Lactulose Hepatic Encephalopathy — FRCA Final MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — IV L-ornithine L-aspartate
Lactulose is the first-line treatment for hepatic encephalopathy. Mechanism: (1) lactulose is metabolised by colonic bacteria to lactic acid, lowering colonic pH which converts ammonia (NH3) to non-absorbable ammonium (NH4+), trapping it in the gut lumen, (2) osmotic laxative effect accelerates gut transit, reducing time for ammonia absorption, (3) may alter colonic bacterial flora. Dose: 15-30 mL 2-3 times daily, titrated to 2-3 soft stools per day. Rifaximin (non-absorbable antibiotic) is added as second-line or for prevention of recurrent episodes. In ICU, lactulose can be given via NG tube or as enema.
Reference: BSG – 2019 – Hepatic encephalopathy guidelines; NICE – 2022 – Cirrhosis management